BioMérieux snags BioFire Diagnostics in $450M buy

French diagnostics developer bioMérieux is ponying up $450 million for the newly renamed BioFire Diagnostics in a move that helps consolidate its position in infectious disease testing. Chairman and CEO Jean-Luc Bélingard envisions using BioFire's Salt Lake City, UT, headquarters and 500-plus employees as foundations for growth in molecular diagnostics. Story